Xtl Biopharmaceuticals (XTLB) Revenue Growth (5y) (2017 - 2018)

Xtl Biopharmaceuticals (XTLB) Revenue Growth (5y) (2017 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xtl Biopharmaceuticals 2.60 Bn 2.60 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2018 16.84%
Jun 30, 2018 -41.86%
Mar 31, 2018 5.39%
Sep 30, 2017 -45.96%
Jun 30, 2017 19.95%
Mar 31, 2017 8.66%